High-dose methotrexate for elderly patients with newly diagnosed primary central nervous system lymphoma

被引:0
|
作者
Zhu, J
Mrugala, M
Nugent, W
Hochberg, F
Batchelor, T
机构
[1] Massachusetts Gen Hosp, Stephen F & Catherine Pappas Ctr Neurooncol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
296
引用
收藏
页码:124 / 124
页数:1
相关论文
共 50 条
  • [41] High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
    Masaki, Yasufumi
    Miki, Miyuki
    Sun, Yue
    Nakamura, Takuji
    Iwao, Haruka
    Nakajima, Akio
    Kurose, Nozomu
    Sakai, Tomoyuki
    Jin, Zhe-Xiong
    Sawaki, Toshioki
    Kawanami, Takafumi
    Fujita, Yoshimasa
    Tanaka, Masao
    Fukushima, Toshihiro
    Hirose, Yuko
    Umehara, Hisanori
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (06) : 720 - 726
  • [42] High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
    Yasufumi Masaki
    Miyuki Miki
    Yue Sun
    Takuji Nakamura
    Haruka Iwao
    Akio Nakajima
    Nozomu Kurose
    Tomoyuki Sakai
    Zhe-Xiong Jin
    Toshioki Sawaki
    Takafumi Kawanami
    Yoshimasa Fujita
    Masao Tanaka
    Toshihiro Fukushima
    Yuko Hirose
    Hisanori Umehara
    [J]. International Journal of Hematology, 2011, 93 : 720 - 726
  • [43] Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients
    Jalaeikhoo, Hasan
    Yekaninejad, Mir Saeed
    Hajizamani, Saeideh
    Rahim, Fakher
    Ahmedzadesh, Ahmed
    Keyhani, Manoutchehr
    Hariri, Behrooz Sadeghi
    Saki, Najmaldin
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2015, 18 (09) : 577 - 581
  • [44] High-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter?
    Joerger, Markus
    Huitema, A. D. R.
    Illerhaus, G.
    Ferreri, A. J. M.
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1825 - 1827
  • [45] HIGH-DOSE METHOTREXATE AND RITUXIMAB WITH DEFERRED RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA
    Chamberlain, Marc C.
    Johnston, Sandra K.
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621
  • [46] First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
    Kaili Zhong
    Yanyan Shi
    Yuhuan Gao
    Huilai Zhang
    Mingzhi Zhang
    Qiaohua Zhang
    Xinan Cen
    Mei Xue
    Yan Qin
    Yu Zhao
    Liling Zhang
    Rong Liang
    Ningju Wang
    Yan Xie
    Yu Yang
    Aichun Liu
    Huizheng Bao
    Jingwen Wang
    Baoping Cao
    Wei Zhang
    Weijing Zhang
    [J]. BMC Cancer, 23 (1)
  • [47] Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma
    Seiichiro Hirono
    Yasuo Iwadate
    Yoshinori Higuchi
    Toru Serizawa
    Osamu Nagano
    Tomoro Matsutani
    Naokatsu Saeki
    [J]. Journal of Neuro-Oncology, 2015, 123 : 237 - 244
  • [48] Improvement of outcomes of an escalated high-dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study
    Li, Qing
    Ma, Jingjing
    Ma, Yan
    Lin, Zhiguang
    Kang, Hui
    Chen, Bobin
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6115 - 6122
  • [49] First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
    Zhong, Kaili
    Shi, Yanyan
    Gao, Yuhuan
    Zhang, Huilai
    Zhang, Mingzhi
    Zhang, Qiaohua
    Cen, Xinan
    Xue, Mei
    Qin, Yan
    Zhao, Yu
    Zhang, Liling
    Liang, Rong
    Wang, Ningju
    Xie, Yan
    Yang, Yu
    Liu, Aichun
    Bao, Huizheng
    Wang, Jingwen
    Cao, Baoping
    Zhang, Wei
    Zhang, Weijing
    [J]. BMC CANCER, 2023, 23 (01)
  • [50] Orelabrutinib, rituximab, temozolomide and high-dose methotrexate (RMOT) in newly diagnosed primary central nervous system lymphoma (PCNSL): A retrospective analysis on efficacy and safety.
    Xia, Yi
    Cai, Qingqing
    Zhang, Peng
    Tian, Xiaopeng
    Fang, Xiaojie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)